Yuqin Liu

7PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 04, 2026
Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines.

|Apr 21, 2026
Establishment and characterization of a novel HBV-integrated hepatic sarcomatoid carcinoma cell line.

|Oct 28, 2025
TPM3-NTRK1 fusion confers resistance to osimertinib in lung adenocarcinoma: a model in a continuous cell line.

Fang Cao, Jiayin Dai, Kun Dong

|Jun 28, 2025
MYC promotes group 3 medulloblastoma cell proliferation and alleviates ROS-induced cell death by upregulating transketolase.

Shizun Wang, Dan Zhang, Chunlong Wang

|May 13, 2025
Fatty acid metabolism-related risk signature revealing the immune landscape of neuroblastoma and predicting overall survival in pediatric neuroblastoma patients.

Shizun Wang, Dan Zhang, Ming Ge

|Apr 25, 2024
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.

Shizun Wang, Dan Zhang, Jialin Wang

Pageof 2

Frequent Collaborators

3 joint publications

Shizun Wang

3 joint publications

Dan Zhang

2 joint publications

Fang Cao

1 joint publications

Yanhua Bai